home / stock / bway / bway news

BWAY News and Press, BrainsWay Ltd. From 03/28/22

Stock Information
Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com
Menu
BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...
BWAY - BrainsWay Appoints Dr. Joachim Seidel as Vice President of Corporate Development and Strategy

BURLINGTON, Mass. and JERUSALEM, March 28, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appoi...
BWAY - BrainsWay to Host Key Opinion Leader Webinar on Deep TMS(TM) Therapy for Treating Anxious Depression

BURLINGTON, Mass. and JERUSALEM, March 15, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it w...

BWAY - BrainsWay's (BWAY) CEO Christopher von Jako on Q4 2021 Results - Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q4 2021 Earnings Conference Call March 9, 2022 8:30 AM ET Company Participants Bob Yedid – Managing Director-LifeSci Advisors, LLC Christopher von Jako – President and Chief Executive Officer Scott Areglado – Chief Financial Officer Conference Call P...

BWAY - Brainsway GAAP EPS of -$0.04 beats by $0.02, revenue of $8.47M beats by $0.23M

Brainsway press release (NASDAQ:BWAY): Q4 GAAP EPS of -$0.04 beats by $0.02. Revenue of $8.47M (+19.8% Y/Y) beats by $0.23M. For further details see: Brainsway GAAP EPS of -$0.04 beats by $0.02, revenue of $8.47M beats by $0.23M

BWAY - BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights

Revenue Growth of 34% in 2021, with Record Quarterly and Annual Revenues Continued Progress in Expanding FDA Labeling for Deep TMS™ and Increasing Payor Coverage Conference call to be held today, March 9, 2022, at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, ...

BWAY - BrainsWay to Present at the 32nd Annual Oppenheimer Healthcare Conference

BURLINGTON, Mass. and JERUSALEM, March 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Chri...

BWAY - BrainsWay to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022

BURLINGTON, Mass. and JERUSALEM, Feb. 28, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it wi...
BWAY - BrainsWay Announces Publication of Results Demonstrating Efficacy of Deep TMS(TM) in Treating Anxiety Symptoms Comorbid to Depression

BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the pu...

BWAY - BrainsWay to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

BURLINGTON, Mass. and JERUSALEM, Feb. 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Chris...

BWAY - BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS(TM) for the Treatment of OCD

BURLINGTON, Mass. and JERUSALEM, Jan. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that a fin...
Previous 10 Next 10